- Home
- CMND vs ISPC Comparison
CMND vs ISPC Comparison
Compare CMND & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMND | ISPC |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.6M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CMND | ISPC |
|---|---|---|
| Price | $6.43 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 49.4K | ★ 104.7K |
| Earning Date | 09-10-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | N/A | $638.10 |
| Revenue Next Year | N/A | $17.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.91 |
| 52 Week High | $7.16 | $115.00 |
Technical Indicators
Market Signals| Indicator | CMND | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 81.01 | 24.08 |
| Support Level | $0.65 | N/A |
| Resistance Level | $7.16 | $1.15 |
| Average True Range (ATR) | 0.46 | 0.07 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 86.21 | 5.85 |
Price Performance
Historical ComparisonAbout CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.